SCHEMBL13715624

SCHEMBL13715624

C[C@H]1CN(c2ccccc2)CCN1C=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.42
▸ FAAH O00519 2/20 0.40
▸ SIGMAR1 Q99720 2/20 0.40
▸ CHRNA7 P36544 1/20 0.40
▸ CTSB P07858 1/20 0.39
▸ CTSS P25774 1/20 0.39
▸ CTSK P43235 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ AGTR2 P50052 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ MBTD1 Q05BQ5 1/20 0.38
▸ L3MBTL3 Q96JM7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19049368 1.00 NOTUM (0.42) NOTUMFAAHSIGMAR1CHRNA7CTSB
SCHEMBL28956406 0.84 ALDH1A1 (0.42) CTSBMAPTLMNAPOLBHTT
SCHEMBL27759918 0.84 GSK3B (0.42) MAPTTSHRHTTCYP2D6GSK3B
SCHEMBL27781453 0.83 GRM1 (0.52) CHRNA7GSK3B
SCHEMBL27542639 0.82 NOTUM (0.41) NOTUMSIGMAR1MAPTTSHRDRD2
SCHEMBL14473329 0.81 ALDH1A1 (0.34) HRH3ALDH1A1
SCHEMBL27702488 0.77 GRM1 (0.54) MAPTTSHRALDH1A1DRD2CYP2D6
SCHEMBL3567530 0.75 ESR1 (0.52) NOTUMSIGMAR1CHRNA7DRD2
SCHEMBL12662987 0.75 ESR1 (0.52) NOTUMSIGMAR1CHRNA7DRD2
SCHEMBL13380548 0.75 ESR1 (0.52) NOTUMSIGMAR1CHRNA7DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531822-B1 1-ARYL-4-SUBSTITUTED PIPERAZINE DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS CHEMOCENTRYX INC (US) 2009-08-05 — — EP disclosed
Send feedback